VeriMommagnolia kobus bark extract hamilelikte güvenli mi?
No EU ban/restriction or harmonised CMR classification found for Magnolia kobus bark extract/CAS 223749-80-2 (CosIng entry exists), but animal studies on major Magnolia bark constituents (honokiol, magnolol) report embryo–fetal effects or placental/uterine effects in rodents, so reproductive hazard is suspected. Example studies: an embryo–fetal toxicity study of honokiol in pregnant rats and animal data showing magnolol alters placental morphology and can inhibit uterine contraction. CosIng/industry listings and EWG do not override these animal findings. Sources: PubMed studies and WHO monograph noted below.
Pregnancy-safe products containing magnolia kobus bark extract
Hamilelikte magnolia kobus bark extract yerine kullanılabilecek güvenli alternatifler | VeriMom
Related ingredients
Frequently asked questions
- magnolia kobus bark extract hamilelikte güvenli mi?
- No EU ban/restriction or harmonised CMR classification found for Magnolia kobus bark extract/CAS 223749-80-2 (CosIng entry exists), but animal studies on major Magnolia bark constituents (honokiol, magnolol) report embryo–fetal effects or placental/uterine effects in rodents, so reproductive hazard is suspected. Example studies: an embryo–fetal toxicity study of honokiol in pregnant rats and animal data showing magnolol alters placental morphology and can inhibit uterine contraction. CosIng/industry listings and EWG do not override these animal findings. Sources: PubMed studies and WHO monograph noted below.
- magnolia kobus bark extract emzirirken güvenli mi?
- No harmonised classification or EU Annex II/III listing found; however the same animal data and mechanistic evidence (placental/uterine activity and systemic activity of isolated constituents) justify a suspected hazard and demonstrated mechanism. Transfer into breastmilk is not directly studied for the extract, but systemic bioactivity of honokiol/magnolol supports cautious classification as suspected (h=2). Exposure from topical cosmetic use is likely low but measurable.
- magnolia kobus bark extract bebek cildi için güvenli mi?
- Baby skin exposure: do not increase h or m without infant-specific evidence, but exposure score is increased because infant skin has higher absorption. The ingredient contains small lipophilic active constituents (honokiol/magnolol) with demonstrated systemic activity in animals; therefore exposure for 0–3 yr olds is scored higher (adult e=1 → baby e=2). No infant-specific safety studies located.
- VeriMom magnolia kobus bark extract nasıl puanlıyor?
- VeriMom magnolia kobus bark extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 40/100 (orta risk) olarak puanlar.
- Hamilelikte magnolia kobus bark extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.